Regulation A · Tier 2
Jabez Biosciences, Inc.
Jabez Biosciences, Inc. filed a Tier 2 Regulation A offering statement (Form 1-A) on Sep 23, 2024 for up to $10M at $2.00 per security. The SEC qualified the offering on Dec 20, 2024.
- Status
- Qualified
- Tier
- Tier 2
- Offering size
- $10M
- Offer price
- $2.00
- Security type
- Equity (common or preferred stock)
- Filed
- Sep 23, 2024
- Qualified
- Dec 20, 2024
- Industry
- Pharmaceutical Preparations
- State
- IN
More on this offering for subscribers
- Revenue, net income and total assets from the offering statement
- Employees
- Market cap at the offer price
- Amount raised, from the exit report (Form 1-Z)
- Auditor
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Offering statement (Form 1-A) Sep 23, 2024
- Exit report (Form 1-Z)
- All filings on EDGAR CIK 2038185
Other qualified Biotech & pharma Reg A offerings
- Turn Therapeutics Inc.Mar 31, 2025 · $18.1M
- Cytonics CorpMar 14, 2025 · $24M
- Medicus Pharma Ltd.Mar 6, 2025 · $12.2M
- Nok Therapeutics, Inc.Jan 3, 2025 · $10M
- Regen BioPharma IncDec 10, 2024 · $0
- BirchBioMed Inc.Oct 8, 2024 · $10M